Boehringer Ingelheim International GmbH

Allemagne


 
Quantité totale PI 4 751
Quantité totale incluant filiales 4 753 (+ 8 pour les filiales)
Rang # Quantité totale PI 226
Note d'activité PI 4/5.0    2 152
Rang # Activité PI 317
Parent C.H. Boehringer Sohn AG & Co. KG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 340 431
348 317
1 593 651
71
 
Dernier brevet 2025 - New therapeutic combinations for...
Premier brevet 1979 - Preparation for the treatment of...
Dernière marque 2024 - HER2.m+
Première marque 1965 - PERSANTINE

Filiales

2 subsidiaries with IP (8 patents, 0 trademarks)

1 subsidiaries without IP

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Provision of medical research information and scientific information in the field of oncology.
P/S Provision of medical research information and scientific information in the field of oncology.
P/S Scientific research in the field of prevention and treatment of metabolic disease; providing medi...
P/S Medical and scientific research in the fields of metabolic diseases, providing medical and scient...
P/S Medical and scientific research in the fields of metabolic diseases; providing medical and scient...
P/S Pharmaceutical preparations.
P/S Scientific research in the field of prevention and treatment of metabolic diseases; providing med...
P/S Scientific research in the field of prevention and treatment of metabolic diseases; providing me...
P/S Medical and scientific research in the fields of metabolic diseases, providing medical and scien...
P/S Medical and scientific research in the field of mental health; providing medical and scientific r...
P/S Medical and scientific research in the field of mental health; providing medical and scientific ...
P/S Medical and scientific research in the field of inflammatory diseases; providing medical and scie...
P/S Medical and scientific research in the field of inflammatory diseases; providing medical and sci...
Invention Anti il-36r antibodies. The present invention relates to anti-IL-36R binding compounds, in parti...
P/S Scientific research in the field of prevention and treatment of cardiovascular diseases; providin...
P/S Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the ali...
P/S Medical and scientific research in the fields of metabolic diseases; providing medical and scien...
Invention Novel substituted pyrazine-carboxamide derivatives. The present invention relates to compounds o...
Invention Cardiosafe antidiabetic therapy. The present invention relates to cardio-safe antidiabetic therapy
Invention Cardio- and renosafe antidiabetic therapy. The present invention relates to cardio- and renosafe...
Invention Anti-il-36r antibodies for the treatment of neutrophilic dermatoses. The present invention provi...
Invention Substituted 1h-pyrazolo[4,3-c]pyridines and derivatives as egfr inhibitors. The present inventio...
Invention Methods for the treatment of gpp. The present invention relates to the treatment of or alleviati...
Invention Treatment of cognitive impairment associated with schizophrenia. The invention relates to the tr...
Invention Pharmaceutical composition, methods for treating and uses thereof. The invention relates to a ph...
Invention Holding device for dispensing devices for substance dispensing of at least one therapeutically an...
Invention Methods for the treatment and prevention of gpp. The present invention relates to the treatment ...
Invention Methods for the treatment and prevention of gpp. The present invention relates to the treatment o...
Invention Pyridine derivatives with n-linked cyclic substituents as cgas inhibitors. The invention relates...
Invention Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer. Th...
Invention Survivin as a biomarker for predicting the responsiveness of cancer treatment. The present invent...
Invention Spirocyclic annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer. The...
Invention Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome. The present i...
Invention Uses of t cell engaging proteins in the treatment of cancer. The invention generally relates to t...
Invention Uses of t cell engaging proteins in the treatment of cancer. The invention generally relates to ...
Invention Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations...
Invention Formulations to stabilize virus-based therapeutics. The present invention relates to viral formu...
Invention Formulations to stabilize virus-based therapeutics. The present invention relates to viral formul...
Invention 7-(4-chlorobenzyl)-1-(3-hydroxypropyl)-3-methyl-8-(3-(trifluoromethoxy)-phenoxy)-3,7-dihydro-1h-p...
Invention Methods for continuously inactivating a virus during manufacture of a protein. Methods for conti...
Invention Heterobicyclic amides as inhibitors of cd38. The present invention relates to heterobicyclic ami...
Invention Dosing schedule of a her2 inhibitor. The present invention relates to a dosing schedule of a HER2...
Invention Formulations comprising polysorbate. Formulations comprising polysorbate and citrate are disclose...
Invention New polymorphs for a piperidino-dihydrothienopyrimidine sulfoxide. The invention concerns new cry...
Invention Phenylpiperidine derivatives as inhibitors of glutaminyl-peptide cyclotransferase and glutaminyl-...
Invention Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs). The invention...
Invention Use of anti-il-36r antibodies for the treatment of hidradentitis suppurativa (hs). The invention ...
Invention Method for testing the integrity of virus filtration modules and a filtration apparatus for carry...
Invention New therapeutic combinations for the treatment of progressive fibrosing interstitial lung disease...
Invention [1,3]thiazolo[4,5-d]-pyrimidon-7-ones as inhibitors of nox4. The present disclosure provides [1,...
Invention Use of anti-cd40 antibodies for treatment of inflammatory conditions. The present invention rela...
Invention [1,3]thiazolo[4,5-d]-pyrimidin-7-ones as inhibitors of nox4. The present disclosure provides [1,3...
Invention Anti-sema3a antibodies and their uses for treating eye or ocular diseases. The present invention...
2023 Invention Anti-cd40 antibodies for use in treating autoimmune disease. The present invention relates to ne...
Invention Tetrazole derivatives as trpa1 inhibitors. The present disclosure provides certain tetrazole der...
2022 Invention Trpc6 inhibitory compounds for treating sepsis. The present invention relates to compounds of fo...
Invention Adamts14 inhibition. Methods of treating and preventing fibrosis, and diseases/disorders charact...
Invention Quantification method of polysorbate in aqueous formulations. The present disclosure is directed...
Invention Medicament for preventing and/or treating dry eye. A compound useful for preventing or treating ...
Invention Method of determining a future color value or corresponding property and arrangement therefor. T...
Invention Anti-il1rap antibodies. The present invention relates to anti-IL1RAP binding compounds, in parti...
2021 Invention Formulation for multi-purpose application. The present invention relates in general to the formu...